Nuvation Bio Inc. (NUVB) NYSE

3.20

+0.19(+6.31%)

Updated at September 26 04:00PM

Currency In USD

Valuation

Market Cap714.93M
Enterprise Value688.13M
P/E Ratio-5.37
PEG Ratio-0.07
Price/Sales Ratio76.3
Price/Book Ratio2.92
Enterprise/Revenue73.19
Enterprise/EBITDA-5.06

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-14.13
Operating Margin-15.65

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.46

Income Statement

Revenue7.87M
Revenue/Share0.04
Gross Profit795,000
EBITDA-566.92M
Net Income-567.94M
Diluted EPS-2.11

Balance Sheet

Total Cash607.72M
Total Cash/Share1.78
Total Debt203.37M
Total Debt/Equity0.55
Current Ratio9.39
Book Value Per Share1.09

Price History

52-Week Change39.74
52-Week High4.09
52-Week Low1.54
Moving Average 50 Days2.83
Moving Average 200 Days2.38

Statistics

Average Volume5.7M
Shares Outstanding342.27M
% Held by Institutions63.08

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A